Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jun;29(3):146-63.
doi: 10.1007/s11096-006-9042-6. Epub 2007 Feb 2.

Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review

Affiliations
Review

Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review

Vera von Gunten et al. Pharm World Sci. 2007 Jun.

Abstract

Aim of the review: To identify and review the clinical and economic impact of pharmacists' interventions on antibiotic use.

Method: A literature search was conducted on Medline (1966-2003) to identify original articles measuring the impact of pharmacists' interventions on antimicrobial therapy at patient's or prescriber's level.

Results: Forty-three articles were included: 20 uncontrolled before-after studies, four controlled before-after studies, five controlled trials, 12 randomized controlled trials and two interrupted time series (ITS). The described interventions were grouped into four categories: patient-specific recommendations (pharmacists' interventions concerning patient-specific drug therapy), implementation of policies, education, and therapeutic drug monitoring. These interventions were often combined to provide a multifaceted intervention, making it difficult to isolate the impact of one specific intervention. Measured outcomes were: appropriateness of prescribing (evaluated in 17 studies, 16 showing significant improvement), costs (analysed in 22 studies, nine showing a statistically significant reduction in costs after or with the intervention), and length of hospital stay (mixed results). Other measured outcomes were: drug use, prescriptions, length of treatment, dose intervals, switch to oral route, mortality rate, and treatment failure.

Conclusion: Over the years, the number of studies and quality of methodology has increased. The most frequently observed outcomes with a positive impact were appropriateness of prescribing and cost savings. The vast majority of studies used multiple interventions, in conjunction with pharmacists' recommendations to physicians. Coupled with the use of practice guidelines or educational strategies, these interventions demonstrated a positive impact on economic or clinical outcomes. However, the data are still sparse and sometimes contradictory; therefore, further studies with randomized controlled designs are needed.

PubMed Disclaimer

References

    1. Am J Health Syst Pharm. 2002 Nov 15;59(22):2209-15 - PubMed
    1. Am J Hosp Pharm. 1983 Nov;40(11):1945-51 - PubMed
    1. Am J Hosp Pharm. 1992 Aug;49(8):1946-50 - PubMed
    1. BMJ. 1998 Aug 15;317(7156):465-8 - PubMed
    1. Int J Technol Assess Health Care. 2001 Spring;17(2):171-80 - PubMed

Substances